Conexiant’s news site is now MDSpire News. Learn more
Advertisement
ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer
Vincent (Wenxin) Xu, MD , shows among patients with advanced kidney cancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors.